Pune, June 12, 2020 (GLOBE NEWSWIRE) -- The global cystic fibrosis market size is predicted to reach USD 31.88 billion by 2027, exhibiting a CAGR of 24.4% during the forecast period. The growing cases of respiratory and gastrointestinal infection among people can be a critical factor in spurring the demand of the market during the forecast period, states Fortune Business Insights in a report, titled “Cystic Fibrosis Market Size, Share & Covid-19 Impact Analysis, By Drug Class (Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies, and Hospital Pharmacies), and Regional Forecast, 2020-2027” the market size stood at USD 5.12 billion in 2019.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cystic-fibrosis-market-102958
Market Driver:
Rising Adoption of Advanced Treatment Procedures to Augment Growth
The rising concentration towards early diagnosis will have a positive impact on the market during the forecast period. The rising cases of genetic disorders have led to the expansion of the market. According to the Cystic Fibrosis Patient Registry, it is estimated that more than 30,000 people are affected by Cystic Fibrosis conditions in the U.S. and it is estimated that about 70,000 people are suffering from it across the globe. The growing complications in the lungs and pancreas consequently indicate cystic fibrosis, which in turn, will augur well for the market.
Moreover, the development of innovative and advanced therapeutics for the treatment of fibrosis will have a tremendous impact on the market in the forthcoming years. For instance, the introduction of Ivacaftor / Lumacaftor, a potentiator used in the treatment for people with CF. In addition, the ongoing pipeline candidates in R&D by leading players will further amplify the growth prospects of the market during the forecast period.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
To get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/cystic-fibrosis-market-102958
Regional Analysis:
High Healthcare Expenditure to Boost Market in North America
The market in North America generated a revenue of USD 3.89 billion in 2019 and is expected to rise rapidly during the forecast period owing to the growing prevalence of CF in the region. The increasing R&D investment by major industry players will contribute positively to the growth of the market. The rising healthcare expenditure along with developed medical facilities will foster growth in the region. The inclination towards advanced drugs by patients for better outcomes will further improve the scope of the market in North America.
Asia Pacific is predicted to account for the lion’s share during the forecast period owing to the rising geriatric patients. Improving healthcare facilities will enable the expansion of the market in Asia Pacific. The rising awareness regarding the treatment of CF will have a positive effect on the market. The Middle East& Africa and Latin America are predicted to witness a steady growth rate owing to the unmet patient needs. The lack of awareness about diseases will further limit growth in the regions.
Quick Buy - Cystic Fibrosis Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102958
Key Development:
October 2019: Approval of Vertex’s Trikafta by the US FDA is the first triple combination therapy used to treat patients suffering from cystic fibrosis.
List of the Key Companies Operating in the Cystic Fibrosis Market are:
- Vertex Pharmaceuticals Incorporated
- AbbVie Inc.
- Novartis AG
- Gilead Sciences, Inc.
- Mylan N.V.
- Pfizer Inc.
- Bayer AG
- Genentech, Inc.
- AstraZeneca
- Others
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cystic-fibrosis-market-102958
Detailed Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- New Product Launches
- Prevalence of Cystic Fibrosis
- Pipeline Analysis
- Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
- Global Cystic Fibrosis Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Class
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Market Analysis, Insights and Forecast – By Route of Administration
- Oral
- Parenteral
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia pacific
- Rest of the World
Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/cystic-fibrosis-market-102958
Have a Look at Related Reports:
Respiratory Drugs Market Size, Share & Industry Analysis, By Drug Class (Short-Acting Beta2-Agonists, Long-Acting Beta2-Agonists, Inhaled Corticosteroids, Anticholinergics, Antihistamines) By Disease Type (Asthma, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease, Pleural Effusion), By Route of Administration (Inhalation, Enteral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecast, 2019-2026
Acute Respiratory Distress Syndrome Treatment Market Size, Share and Global Trend By Drug Class (Vasoconstrictors, Bronchodilators, Steroids and Antibiotics, Nitric Oxide, Sedatives & Paralytics, Surfactant), By Route of Administration (Oral, Injection, Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Geography Forecast till 2026
Respiratory Devices Market Size, Share & Industry Analysis, By Product (Therapeutic Devices, Monitoring Devices), By Indication (Asthma, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease (COPD), Pleural Effusion, Others) and Regional Forecast, 2019-2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/cystic-fibrosis-market-10008